Songpeng Yang

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 3

Top Topics

Endoplasmic Reticulum

Acute Coronary Syndrome

Top Venues

Proceedings of the National Academy of Sciences of the United States of America

British journal of pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Zhiwen Gu, Lei Wang, Qian Dong, Kaikun Xu, Jingnan Ye, Xianfeng Shao, Songpeng Yang, Cuixiu Lu, Cheng Chang, Yushan Hou, Yuanjun Zhai, Xinxin Wang, Fuchu He, Aihua Sun
Aberrant LYZ expression in tumor cells serves as the potential biomarker and target for HCC and promotes tumor progression via csGRP78. Proceedings of the National Academy of Sciences of the United States of America 120 (29) (2023)
Songpeng Yang, Shu Yang, Hongying Zhang, Hui Hua, Qingbin Kong, Jiao Wang, Yangfu Jiang
Targeting Na+ /K+ -ATPase by berbamine and ouabain synergizes with sorafenib to inhibit hepatocellular carcinoma. British journal of pharmacology 178 (21) (2021)
Hongying Zhang, Songpeng Yang, Jiao Wang, Yangfu Jiang
Blockade of AMPK-Mediated cAMP-PKA-CREB/ATF1 Signaling Synergizes with Aspirin to Inhibit Hepatocellular Carcinoma. Cancers 13 (7) (2021)